TickerGuard
Buy Day today: Neutral (51) Mixed market breadth · no major macro event
REPL

Replimune Group Inc

Healthcare · Biotechnology

13.10$ +1.6% vs. previous close Closing price · As of: Sep 18, 2026

Statements

Income Statement

All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.

Tick rows to compare them in a chart (up to 4)

Income Statement REPL
Line item 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026
-10.7% +35.8% +1,120.9% +129.1% +10.5% -46.5% +8.5% +31.9%
+94.9% +64.1% +74.8% +48.3% +40.3% +56.9% +38.3% +8.3% +16.8%
+110.7% +53.6% +88.7% +40.2% +67.1% +30.4% +18.3% +20.7% +36.8%
+106.7% +67.5% +97.8% +39.9% +48.7% +51.5% +32.6% +11.4% +22.3%
+59.5% -27.4% +87.1% +60.1% +18.5% +12.2%
-1,744.8% +322.0% -247.5% +41.7% +14.7% -217.7%

Data as of: September 18, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?